Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pseudoephedrine Prophylaxis for Middle Ear Barotrauma in HBOT
NCT05697328Recruiting
- Sponsor
- John Muir Health
- Start
- Jan 2023
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Middle ear barotrauma (MEBT) comparing Pseudoephedrine with Placebo (2 arms). Primary endpoint: Changes in self-reported ear pain. Started Jan 2023; status: recruiting.
02
Drugs
pseudoephedrine
03
Conditions
Middle ear barotrauma (MEBT)
Beyond the preview
Go deeper on NCT05697328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05697328.